COVID-19 IgM/IgG Rapid Test Approved by INVIMA in Colombia!

We are excited to announce that the National Institute for Food and Drug Surveillance (INVIMA) has given BioMedomics, Inc. authorization to sell and distribute our COVID-19 IgM/IgG Rapid Test in Colombia!

We have partnered with Piso Pélvico-GILMEDICA S.A. to assist with distributing our product to customers. For sales requests in Colombia, please contact Mr. Julián Potes by email (julian.potes@gilmedica.com) or phone (+57 318 827 49 94).

BioMedomics’s COVID-19 IgM/IgG Rapid Test is one of the first and most accurate COVID-19 antibody rapid tests on the market, winning over competitor testing methods with:

  • Fastest test result of 10-15 minutes
  • Highest combined sensitivity/specificity (100%/~99%)
  • Intuitive visual interpretation
  • No special equipment needed

For information or questions about our COVID-19 IgM/IgG Rapid Test, please email info@biomedomics.com

To receive a quote and place an order, please email sales@biomedomics.com

*Not available for sale within the USA.

Share:

Share on facebook
Share on twitter
Share on linkedin

RECOMMENDED POSTS

Comments are closed for this article!